IL13RA2 and glioblastoma: Through epigenetic silencing of oncogenes such as IL13RA2, overexpression of KMT5B reduced glioblastoma cell proliferation, cell viability, clonogenic potential in vitro, and tumor growth in vivo (López et al., 2021; Hulen et al., 2022).